FindTrial
Sign In

Chinese Multicenter Collaboration Platform for Patent Ductus Arteriosus in Extremely Preterm Infants

Chinese Multicenter Collaboration Platform for Patent Ductus Arteriosus in Extremely Preterm Infants

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400091371
Enrollment
Unknown
Registered
2024-10-28
Start date
2024-11-01
Completion date
Unknown
Last updated
2024-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patent ductus arteriosus

Interventions

Total study population:None

Sponsors

Children’s Hospital of Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All extremely preterm infants born at a gestational age of =29+6 weeks admitted to the neonatal intensive care unit (NICU) of members of the collaborative platform within 3 days of birth during the study period

Exclusion criteria

Exclusion criteria: The family of the child refused to be enrolled in the study

Design outcomes

Primary

MeasureTime frame
hemodynamically significant patent ductus arteriosus;in-hospital death;bronchopulmonary dysplasia;—

Countries

China

Contacts

Public ContactAimin Qian

Children’s Hospital of Nanjing Medical University

exploiter_qian@163.com+86 137 7091 4063

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026